A methodology for optimizing the beam directions in radiotherapy treat
ment planning has been developed and tested on a cohort of twelve pros
tate patients. An optimization algorithm employing an objective cost f
unction was used, based on beam's-eye-view volumetrics but also employ
ing a simple dose model and biological considerations for organs-at-ri
sk (OARs). The cost function embodies information about the volume of
OARs in a single field and their position relative to the planning tar
get volume (PTV). The proximity of the PTV to the surface of the patie
nt is also included. Within the algorithm ''importance factors'' were
used to model the clinical importance of different organs-at-risk so t
hat all organs-at-risk were included in a single objective score. ''Ga
ntry-angle-windows'' were introduced to restrict the available beam di
rections. The methodology was applied to twelve prostate patients to d
etermine the optimum beam directions for three-field direction plans.
Orientation-optimized and standard treatment plans were compared via m
easures of tumor control probability (TCP) and normal tissue complicat
ion probability (NTCP). Standard plans had fixed beam directions where
as orientation-optimized plans contained beam directions chosen by the
algorithm. The beam-weights of both the orientation-optimized and sta
ndard plans were optimized using a dose-based simulated annealing algo
rithm to allow the improvements by optimizing the beam directions to b
e studied in isolation. The results of the comparison show that optimi
zation of the beam directions yielded better plans, in terms of TCP an
d NTCP, than the standard plans. When the dose to the isocenter was sc
aled to produce a rectal NTCP of 1%, the average TCP of the orientatio
n-optimized plans was (5.7 +/- 1.4)% greater than that for the standar
d plans. In conclusion, the customization of beam directions in the tr
eatment planning of prostate patients using an objective cost function
and allowed gantry-angle-windows produces superior three-field direct
ion plans compared to standard treatment plans. (C) 1998 American Asso
ciation of Physicists in Medicine.